Medidata Solutions, Inc. announced its expanded partnership with Karyopharm Therapeutics. In 2014, Karyopharm selected one Medidata technology solution for a single study. The company is leveraging 10 solutions in Medidata Rave Clinical Cloud in more than 15 clinical studies focused on hematologic malignancies and solid tumors. With Medidata solutions, Karyopharm is able to: Centralize operations, eliminate manual data entry, and operate with a clear view of all cross-application data in one place; Simplify and customize reporting within or across studies and leverage over 30 standard reports; Reduce complexity by standardizing and improving data quality with powerful artificial intelligence and machine learning algorithms that automatically manage the complexity of clinical data.